N. Ates Et Al. , "Phosphorylation of PI3K/Akt at Thr308, but not phosphorylation of MAPK kinase, mediates lithium-induced neuroprotection against cerebral ischemia in mice," Experimental Neurology , vol.351, 2022
Ates, N. Et Al. 2022. Phosphorylation of PI3K/Akt at Thr308, but not phosphorylation of MAPK kinase, mediates lithium-induced neuroprotection against cerebral ischemia in mice. Experimental Neurology , vol.351 .
Ates, N., ÇAĞLAYAN, A., Balcikanli, Z., Sertel, E., BEKER, M. Ç., Dilsiz, P., ... ÇAĞLAYAN, A. B.(2022). Phosphorylation of PI3K/Akt at Thr308, but not phosphorylation of MAPK kinase, mediates lithium-induced neuroprotection against cerebral ischemia in mice. Experimental Neurology , vol.351.
Ates, Nilay Et Al. "Phosphorylation of PI3K/Akt at Thr308, but not phosphorylation of MAPK kinase, mediates lithium-induced neuroprotection against cerebral ischemia in mice," Experimental Neurology , vol.351, 2022
Ates, Nilay Et Al. "Phosphorylation of PI3K/Akt at Thr308, but not phosphorylation of MAPK kinase, mediates lithium-induced neuroprotection against cerebral ischemia in mice." Experimental Neurology , vol.351, 2022
Ates, N. Et Al. (2022) . "Phosphorylation of PI3K/Akt at Thr308, but not phosphorylation of MAPK kinase, mediates lithium-induced neuroprotection against cerebral ischemia in mice." Experimental Neurology , vol.351.
@article{article, author={Nilay Ates Et Al. }, title={Phosphorylation of PI3K/Akt at Thr308, but not phosphorylation of MAPK kinase, mediates lithium-induced neuroprotection against cerebral ischemia in mice}, journal={Experimental Neurology}, year=2022}